Boston Scientific Corporation BSX
41.98 USD -1.01 (-2.35%)
Regular-session close
42.20 +0.22 +0.52%
After hours · Nov 20, 7:52 PM ET
41.92 Day range 43.22
41.58 52-week range 101.58
- YTD
- -55.97%
- 1 year
- -56.54%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 20.07B | 16.75B | 14.24B | 12.68B | 11.89B | |
| 13.85B | 11.49B | 9.89B | 8.73B | 8.18B | |
| 3.61B | 2.60B | 2.34B | 1.65B | 1.20B | |
| 2.90B | 1.85B | 1.59B | 698.00M | 1.04B | |
| 1.94 | 1.25 | 1.07 | 0.45 | 0.69 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.97B | 414.00M | 865.00M | 928.00M | 1.93B | |
| 43.67B | 39.40B | 35.14B | 32.47B | 32.23B | |
| 19.20B | 17.39B | 15.61B | 14.90B | 15.61B | |
| 11.44B | 10.75B | 9.10B | 8.94B | 9.06B | |
| 24.23B | 21.77B | 19.28B | 17.57B | 16.62B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 4.53B | 3.44B | 2.50B | 1.53B | 1.87B | |
| -2.64B | -5.69B | -2.57B | -2.01B | -1.60B | |
| -395.00M | 1.81B | 5.00M | -548.00M | -95.00M | |
| -876.00M | -790.00M | -711.00M | -506.00M | -458.00M | |
| 1.54B | -450.00M | -70.00M | -1.04B | 173.00M |
